30+ sources. Zero spin.
Cross-referenced, unbiased news. Both sides of every story.
Markets Brace for SpaceX IPO After Worst Chip Week in Years — OpenAI Government Stake Talks Add New Variable

Since the chip selloff accelerated into Friday's close — with the iShares Semiconductor ETF dropping 10% on the day and the Nasdaq posting its worst week since April 4, 2025 — the market is now trying to figure out what comes next. The answer is: a lot.
The Wreckage, In Numbers
The Nasdaq closed Friday at 25,709.43, down 4.18% on the session and 4.7% for the week, according to CNBC. The S&P 500 shed 2.64% Friday, ending its 9-week winning streak. Individual chip names got destroyed: Marvell Technology fell more than 16%, Micron dropped 13%, Intel and AMD each fell around 11%, and Broadcom lost nearly 8% — after already getting hammered 12% Thursday.
The iShares Semiconductor ETF (SOXX) had its worst single day since March 16, 2020. That's pandemic-crash territory.
Bitcoin cracked $60,000 intraday Friday, hitting $59,099.25 — its lowest since October 2024, according to CNBC. It closed down 16% for the week. Michael Saylor's Strategy (MSTR) dropped 6.9% Friday and 24% for the week — its worst week since November 2022.
What Actually Caused This
The clean narrative from mainstream coverage is Broadcom's failure to raise its AI chip outlook Wednesday night. That's real. But it doesn't fully explain Friday's intensity.
Mark Hackett, chief market strategist at Nationwide, told CNBC the more likely explanation is positioning: investors who rode the semiconductor rocket ship up 79% year-to-date needed to rebalance. "Investors had been kind of hovering with their finger over this sell button," he said. "Not necessarily to get out."
On top of that, a stronger-than-expected May jobs report pushed Treasury yields higher Friday morning, raising rate-hike odds to above 40% by the end of the day according to CME's FedWatch tool. Higher rates hurt risk assets. Chips, bitcoin, and speculative tech took the punch.
Charles-Henry Monchau, CIO at Syz Group, flagged another factor: speculative money is rotating toward AI stocks in Korea and toward the SpaceX IPO next week. "People looking to get into the SpaceX IPO next week, it's unlikely they're going to use Procter & Gamble funds to fund it," Hackett told CNBC.
Is This the Top? Probably Not.
Wharton professor emeritus Jeremy Siegel went on CNBC's Closing Bell Friday and was blunt: "That's rarely the top." He called it a textbook "up the staircase, down the elevator" moment for momentum-driven chip names. Siegel acknowledged it could be a top, but said the more likely outcome is a short-term floor, followed by a test of prior highs — and that test will tell the real story.
Carter Worth of WorthCharting offered the counter-view: chip stocks relative to the broader tech sector have now hit what he calls a potential "triple top" in relative strength. He's in the underweight-semis camp. That's a technical read, not a fundamental one.
SOXX is still up 79% year-to-date even after the carnage. Context matters.
What's Coming Next Week
SpaceX IPO — Friday, June 13. Already set to go public at a $1.77 trillion valuation, this will be the largest IPO in history, according to CNBC. Some strategists believe the selloff this week was partly traders raising cash to participate. Whether that's true or not, the debut will be a sentiment test for whether retail money is still all-in on tech.
Apple WWDC — Monday. CNBC's Jim Cramer club flagged expectations for a "Gemini-powered" Siri update. Apple needs a win here. Tim Cook's AI legacy is on the line at what CNBC called his "final developer conference as CEO."
Inflation Data — Wednesday/Thursday. CPI on Wednesday. PPI on Thursday. With rate-hike odds now above 40% for December after Friday's jobs data, these prints will either pour fuel on that fire or put it out.
Cybersecurity Earnings Aftermath. CrowdStrike and Palo Alto Networks both reported strong quarters and gave upbeat guidance — and BOTH still fell, 8% and 3% respectively, according to CNBC. Joseph Gallo, software analyst at Jefferies, explained it simply: AI benefits from Anthropic's models take time, and enterprise sales cycles run nine to twelve months. Investors wanted a windfall. They got a promise.
The OpenAI Government Stake Story
Buried under the chip carnage: the Trump administration confirmed it is in active talks to take a government equity stake in OpenAI, according to CNBC, which confirmed the reporting first broken by Notus.
Sam Altman floated the idea with the Trump administration back in 2025. The talks continued this week as Altman met lawmakers in Washington. The structure being discussed: OpenAI donates equity to the U.S. government to seed a "Public Wealth Fund" — a vehicle that would let American citizens share in AI's upside.
Trump confirmed the talks Friday while aboard Air Force One. "There are concepts where pieces could be given to the American public, where the American public essentially becomes a partner," he said.
No terms are finalized. Reports have indicated the Trump administration has pursued various technology and industrial equity arrangements during the second term, though the specific contours of any such holdings remain subject to ongoing reporting.
A government equity stake in the world's most powerful AI company raises real questions about conflicts of interest, regulatory capture, and whether any future OpenAI oversight can be truly independent. Sen. Bernie Sanders told CNBC he has concerns — though his framing differs from conservative concerns about government overreach into private enterprise. Both reflect substantive policy disagreements.
The Immediate Outlook
The defensive stocks won Friday. Procter & Gamble gained more than 4%. Utilities, health care, real estate — all up. When boring wins big, the market is telling you something.
Regular investors holding index funds took a hit this week. Those overweight semis took a bigger one. The question now is whether next week's SpaceX debut and inflation data reset the narrative — or confirm that the AI trade finally got too hot for its own good.